Abstract

Introduction: Ross operation provides young adult and pediatric patients a living valve with excellent hemodynamics and no lifelong anticoagulation. However, autograft dilatation is a concern when it leads to aneurysm formation and autograft insufficiency requiring reoperation. Computational simulations of autograft remodeling are potentially effective to predict autograft dilatation, but require zero-pressure geometry and patient-specific material properties for accuracy. Hypothesis: We hypothesized that pulmonary autograft wall stresses estimated from computational simulations using in-vivo imaging would reasonably correlate with the gold standard, wall stresses determined computationally using ex-vivo autograft specimens at zeto-pressure. We recently showed that autograft wall stresses significantly increased immediately after the Ross operation. Our goal was to compare autograft wall stresses based on in-vivo geometry to those based on ex-vivo autografts. Methods: Magnetic resonance imaging (MRI) was obtained in pre-operative Ross patients and used to reconstruct in-vivo autograft geometry. Pre-stress (zero-pressure) geometry was determined. As controls, pulmonary autografts explanted from normal donor hearts underwent micro-computed tomography scans for reconstruction of ex-vivo geometry. Biaxial stretch testing was performed on both intraoperative tissue from Ross patients and on ex-vivo autografts to determine patient-specific material properties. Finite element simulations using LS-DYNA were performed to determine wall stresses. Results: Imaging from ex-vivo pulmonary autografts (n=6) and Ross patients (n=6) were obtained. Peak stresses were 93 kPa for ex-vivo vs. 113 kPa for in-vivo autografts at 25mmHg and 448kPa vs. 558 kPa, respectively at 120mmHg. Conclusions: Wall stresses at pulmonary and systemic systolic pressure predicted by in-vivo MRI imaging reasonably correlated with wall stresses based upon ex-vivo autograft tissue. Computational simulations using in-vivo imaging provides a suitable surrogate for the gold standard simulations using ex-vivo tissue specimens and broadens clinical applicability of computational simulations for patient-specific outcomes.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.